Search Results
Results found for "Yang Du"
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment of a broad range develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment of a broad range
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
The sections below synthesize the key topics addressed during the AMA and highlight the GPCR pharmacology Dual-assay strategies (high and low sensitivity) are essential, not optional. stressed that low-alpha NAMs can resemble competitive antagonists unless deeper kinetic or concentration-range
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
“ A substitution of one amino acid by another in a protein can have effects ranging from negligible to Furthermore, probing species- or subtype-selectivity introduces complexities due to the differing contexts
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
High-affinity agonists reveal recognition motifs for the MRGPRD GPCR Chunyu Wang , Yongfeng Liu , Marion Pancreatic ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed Jillian G Salmerón , Paul A Insel PGxDB: an interactive web-platform for pharmacogenomics research Trinh Trung Duong repurposing to prevent and treat murine colitis and sepsis GPCRs in Oncology and Immunology Pancreatic ductal
- From DNA day to GPCR genomics
beta-adrenergic receptor (βAR), the first GPCR to be identified by Robert Lefkowitz and colleagues during The completion of the Human Genome Project revealed that GPCR genes in the human genome range from approximately This variation is due to factors such as alternative splicing, gene duplications, and variability in crystallography and cryo-electron microscopy, have allowed us to understand the structural dynamics during For example, we know that transmembrane helices move during receptor activation and that the DRY motif
- MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
cytokines along with their receptors, are involved in various biologic processes and regulation of a wide range
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
donors.[17] Lanthanides provide unique advantages as donors, since they have extended fluorescence duration GPCRs are not suitable for antibody use due to steric hindrance and reverse binding, thus, other strategies We have previously used this technology using CELT-335, a dual hCB1/hCB2 fluorescent ligand, which was A.; Bazin, H.; Tinel, N.; Durroux, T.; Prézeau, L.; Trinquet, E.; Pin, J.-P. M.; Roux, T.; Cottet, M.; Durroux, T.; Douzon, S.; Bdioui, S.; Gregor, N.; Bourrier, E.; Oueslati, N.
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
radioactivity-related safety and environmental concerns, while the other one has high background noise and low dynamic range Celtarys custom-developed ligands offer both high affinity and exceptional selectivity across a wide range
- Verily links up with Sosei Heptares for GPCR drug discovery
recent years as researchers have discovered the vast potential for GPCR-targeting drugs in treating a range
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
channel configurations The goal is to achieve a high Z′ factor , reflecting assay robustness and dynamic range homogeneity Spectral separation Environmental control (CO₂, humidity, temperature) prevents drift during
- G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions...
GRK2/β-arrestin2 play multiple roles in the pathological mechanisms of a wide range of diseases including
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
candidate into clinical trials "HTL0039732 is a novel EP4 antagonist with potential to treat a wide range
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
interesting phenotype the lab found where, as a mouse was starting to enter what we consider the chronic pain range
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
However only ~15% of the GPCR superfamily has been successfully drugged, due in part to the intractability small molecule modulators of small protein GPCRs, but discovery is challenging and the attrition rate during Both properties enable enhanced ligands to avoid being eliminated during the stringent washing process This leads to strikingly long in vitro receptor occupancy durations (at least seven days), meaning that This is due to their enhanced capacity to drive receptor internalization in a process that pulls the
- Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...
Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the range of GPA-10 functioned to transduce signals of multiple GPCRs to different downstream signaling pathways during
- VAMP2: a crucial player in the delivery of MOR to the synapse
However, the selectivity of SNARE complex proteins to regulate the release of different types of GPCRs during Wang, F., X. Chen, X. Zhang, and L. Ma. 2008.
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
G protein-coupled receptors (GPCRs) are crucial receptors that regulate a wide range of physiological
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
ligands are versatile molecular tools to study G protein-coupled receptors (GPCRs) and can be used for a range
- β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...
associate with the active parathyroid hormone 1 receptor (PTH1R) in different complex configurations ("hanging
- In vivo detection of GPCR-dependent signaling using fiber photometry and FRET-based biosensors
Hence, it has wide applicability across a spectrum of neuroscience research, ranging from the study of
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
GPCRs respond to a wide variety of signals that range in size from photons to proteins (Foord et al.,
- Cholesterol-Dependent Dynamics of the Serotonin 1A Receptor Utilizing Single Particle Tracking....
2022 "G protein-coupled receptors (GPCRs) are signaling hubs in cell membranes that regulate a wide range
- Cholesterol-Dependent Dynamics of the Serotonin1A Receptor Utilizing Single Particle Tracking: ...
Modes "G protein-coupled receptors (GPCRs) are signaling hubs in cell membranes that regulate a wide range
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
Modern drug development approaches include a range of techniques leveraging structural biology, immunology
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
This event extends the duration of β-arrestin at the plasma membrane, enabling it to independently reach Cell, 185(24), 4560–4573.e19. https://doi.org/10.1016/j.cell.2022.10.018 Latorraca, N.R., Wang, J.K.,
- Newly launched antibody libraries put hard-to-drug targets within reach
The drugs also target relatively low-hanging fruit: like cytokines or tyrosine kinase receptors.
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
fluorescent GPCR ligands "G-protein coupled receptors (GPCRs) have been largely targeted in a wide range
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
fragment- and seven lead-like compounds were confirmed to bind to the allosteric site with affinities ranging
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
diseases, (d) showed spontaneously fluctuating Ca levels from approximately normal to near fatally high ranges
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
fragment- and seven lead-like compounds were confirmed to bind to the allosteric site with affinities ranging








